Beijing, China

Jiguo Su

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 19.0

ph-index = 1


Years Active: 2025

where 'Filed Patents' based on already Granted Patents

1 patent (USPTO):

Title: Jiguo Su: Innovator in Vaccine Development

Introduction

Jiguo Su is a prominent inventor based in Beijing, China. He has made significant contributions to the field of vaccine development, particularly in the fight against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). His innovative work has the potential to impact public health on a global scale.

Latest Patents

Jiguo Su holds a patent for a recombinant severe respiratory syndrome coronavirus 2 RBD trimer protein vaccine. This vaccine is capable of generating broad-spectrum cross-neutralization activity against various SARS-CoV-2 epidemic strains. The invention provides a recombinant RBD trimer protein that serves as an antigen, supplemented with an adjuvant to immunize organisms. This process enables the generation of high-titer neutralizing antibodies targeting multiple SARS-CoV-2 strains, offering a promising approach for treating and preventing SARS-CoV-2 infections and coronavirus disease 2019.

Career Highlights

Jiguo Su is affiliated with the National Vaccine and Serum Institute, where he continues to advance his research and development efforts. His work is crucial in addressing the challenges posed by emerging infectious diseases.

Collaborations

Some of his notable coworkers include Qiming Li and Yu Liang, who contribute to the collaborative efforts in vaccine research and development.

Conclusion

Jiguo Su's innovative contributions to vaccine technology exemplify the importance of research in combating infectious diseases. His work not only enhances our understanding of SARS-CoV-2 but also paves the way for future advancements in vaccine development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…